Cost-effectiveness of family history-based colorectal cancer screening in Australia

BMC Cancer

Table 5 One-way sensitivity analysis of ICER based on screening participation rate

Colonoscopy screening participation rate	ICER COLO₅vs. usual care		ICER COLO₁₀vs. usual care
	Life years gained per 1,000 persons	ICER (AU$)	Life years gained per 1,000 persons	ICER (AU$)
10%	81	17,779	-	Dominated
20%	346	9,108	148	7,835
30%	492	9,089	272	7,612
40% (reference)	561	9,842	361	8,619
50%	699	9,283	416	9,192
60%	717	10,095	476	9,863
70%	775	10,245	547	9,887
80%	824	10,279	609	9,949
90%	871	10,423	641	10,333
100%	880	11,139	722	10,384

ICER: incremental cost-effectiveness ratio, iFOBT₂: immunochemical faecal occult blood test, COLO₅: colonoscopy screening every five years, COLO₁₀: colonoscopy screening every ten years.

ISSN: 1471-2407